Punctuated Evolution of Canonical Genomic Aberrations in Uveal Melanoma

Overview

Journal Nat Commun

Specialty Biology

Date 2018 Jan 11

PMID 29317634

Citations 95

Authors

Matthew G Field

Michael A Durante

Hima Anbunathan

Louis Z Cai

Christina L Decatur

Anne M Bowcock

Stefan Kurtenbach

J William Harbour

Affiliations

Soon will be listed here.

Abstract

Cancer is thought to arise through the accumulation of genomic aberrations evolving under Darwinian selection. However, it remains unclear when the aberrations associated with metastasis emerge during tumor evolution. Uveal melanoma (UM) is the most common primary eye cancer and frequently leads to metastatic death, which is strongly linked to BAP1 mutations. Accordingly, UM is ideally suited for studying the clonal evolution of metastatic competence. Here we analyze sequencing data from 151 primary UM samples using a customized bioinformatic pipeline, to improve detection of BAP1 mutations and infer the clonal relationships among genomic aberrations. Strikingly, we find BAP1 mutations and other canonical genomic aberrations usually arise in an early punctuated burst, followed by neutral evolution extending to the time of clinical detection. This implies that the metastatic proclivity of UM is "set in stone" early in tumor evolution and may explain why advances in primary treatment have not improved survival.

Citing Articles

Identification of diagnostic and prognostic genetic alterations in uveal melanoma using RNA sequencing.

Nell R, Versluis M, Cats D, Mei H, Verdijk R, Kroes W Sci Rep. 2025; 15(1):8167.

PMID: 40059100 PMC: 11891316. DOI: 10.1038/s41598-025-90122-z.

Punctuational evolution is pervasive in distal site metastatic colonization.

Butler G, Amend S, Venditti C, Pienta K Proc Biol Sci. 2025; 292(2039):20242850.

PMID: 39837515 PMC: 11750355. DOI: 10.1098/rspb.2024.2850.

Survival Benefit of Primary Tumor Treatment in Uveal Melanoma: A Re-Analysis of the Collaborative Ocular Melanoma Study (COMS) and Natural History Study (NHS) Cohorts.

Witzenhausen H, Stalhammar G Cancers (Basel). 2024; 16(22).

PMID: 39594794 PMC: 11593181. DOI: 10.3390/cancers16223839.

Identification of targetable epigenetic vulnerabilities for uveal melanoma.

Yenisehirli G, Yenisehirli G, Borges S, Borges S, Braun S, Braun S bioRxiv. 2024; .

PMID: 39416076 PMC: 11482939. DOI: 10.1101/2024.10.11.617464.

Characterization of somatic mutations in sporadic uveal melanoma and uveal melanoma in patients with germline BAP1 pathogenic variants.

Wadt K, Harbst K, Sjol M, Rosengren F, Yde C, Rohrberg K PLoS One. 2024; 19(10):e0306386.

PMID: 39378214 PMC: 11460691. DOI: 10.1371/journal.pone.0306386.

References

Jensen D, Proctor M, Marquis S, Gardner H, Ha S, Chodosh L . BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene. 1998; 16(9):1097-112. DOI: 10.1038/sj.onc.1201861. View

Radenbaugh A, Ma S, Ewing A, Stuart J, Collisson E, Zhu J . RADIA: RNA and DNA integrated analysis for somatic mutation detection. PLoS One. 2014; 9(11):e111516. PMC: 4236012. DOI: 10.1371/journal.pone.0111516. View

Imielinski M, Berger A, Hammerman P, Hernandez B, Pugh T, Hodis E . Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell. 2012; 150(6):1107-20. PMC: 3557932. DOI: 10.1016/j.cell.2012.08.029. View

Martin M, Masshofer L, Temming P, Rahmann S, Metz C, Bornfeld N . Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3. Nat Genet. 2013; 45(8):933-6. PMC: 4307600. DOI: 10.1038/ng.2674. View

Hegele A, Kamburov A, Grossmann A, Sourlis C, Wowro S, Weimann M . Dynamic protein-protein interaction wiring of the human spliceosome. Mol Cell. 2012; 45(4):567-80. DOI: 10.1016/j.molcel.2011.12.034. View

Decatur C, Ong E, Garg N, Anbunathan H, Bowcock A, Field M . Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes. JAMA Ophthalmol. 2016; 134(7):728-33. PMC: 4966162. DOI: 10.1001/jamaophthalmol.2016.0903. View

Shiraishi Y, Tremmel G, Miyano S, Stephens M . A Simple Model-Based Approach to Inferring and Visualizing Cancer Mutation Signatures. PLoS Genet. 2015; 11(12):e1005657. PMC: 4667891. DOI: 10.1371/journal.pgen.1005657. View

Singh A, Topham A . Survival rates with uveal melanoma in the United States: 1973-1997. Ophthalmology. 2003; 110(5):962-5. DOI: 10.1016/S0161-6420(03)00077-0. View

Gao R, Davis A, McDonald T, Sei E, Shi X, Wang Y . Punctuated copy number evolution and clonal stasis in triple-negative breast cancer. Nat Genet. 2016; 48(10):1119-30. PMC: 5042845. DOI: 10.1038/ng.3641. View

10.

Dong C, Wei P, Jian X, Gibbs R, Boerwinkle E, Wang K . Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies. Hum Mol Genet. 2015; 24(8):2125-37. PMC: 4375422. DOI: 10.1093/hmg/ddu733. View

11.

Johansson P, Aoude L, Wadt K, Glasson W, Warrier S, Hewitt A . Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4. Oncotarget. 2015; 7(4):4624-31. PMC: 4826231. DOI: 10.18632/oncotarget.6614. View

12.

Harbour J . The genetics of uveal melanoma: an emerging framework for targeted therapy. Pigment Cell Melanoma Res. 2012; 25(2):171-81. PMC: 4470256. DOI: 10.1111/j.1755-148X.2012.00979.x. View

13.

Harbour J, Onken M, Roberson E, Duan S, Cao L, Worley L . Frequent mutation of BAP1 in metastasizing uveal melanomas. Science. 2010; 330(6009):1410-3. PMC: 3087380. DOI: 10.1126/science.1194472. View

14.

Onken M, Worley L, Long M, Duan S, Council M, Bowcock A . Oncogenic mutations in GNAQ occur early in uveal melanoma. Invest Ophthalmol Vis Sci. 2008; 49(12):5230-4. PMC: 2634606. DOI: 10.1167/iovs.08-2145. View

15.

Zhao J, Sun Y, Huang Y, Song F, Huang Z, Bao Y . Functional analysis reveals that RBM10 mutations contribute to lung adenocarcinoma pathogenesis by deregulating splicing. Sci Rep. 2017; 7:40488. PMC: 5238425. DOI: 10.1038/srep40488. View

16.

Eskelin S, Pyrhonen S, Summanen P, Hahka-Kemppinen M, Kivela T . Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment. Ophthalmology. 2000; 107(8):1443-9. DOI: 10.1016/s0161-6420(00)00182-2. View

17.

Navin N, Kendall J, Troge J, Andrews P, Rodgers L, McIndoo J . Tumour evolution inferred by single-cell sequencing. Nature. 2011; 472(7341):90-4. PMC: 4504184. DOI: 10.1038/nature09807. View

18.

Shihab H, Gough J, Cooper D, Day I, Gaunt T . Predicting the functional consequences of cancer-associated amino acid substitutions. Bioinformatics. 2013; 29(12):1504-10. PMC: 3673218. DOI: 10.1093/bioinformatics/btt182. View

19.

Van Raamsdonk C, Griewank K, Crosby M, Garrido M, Vemula S, Wiesner T . Mutations in GNA11 in uveal melanoma. N Engl J Med. 2010; 363(23):2191-9. PMC: 3107972. DOI: 10.1056/NEJMoa1000584. View

20.

Sottoriva A, Kang H, Ma Z, Graham T, Salomon M, Zhao J . A Big Bang model of human colorectal tumor growth. Nat Genet. 2015; 47(3):209-16. PMC: 4575589. DOI: 10.1038/ng.3214. View